V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10009163 | 10005058 | 1.69 | 56 | Palliative (P) | 2016-12-16 | 2016-12-16 | ECX | N | N | 10514673 | CETUXIMAB + OXALIPLATIN + MDG |
| 10009164 | 10005079 | 1.81 | 66 | Palliative (P) | 2019-03-25 | 2019-03-25 | Bortezomib +/- Dexamethasone | N | null | 10517435 | BORTEZOMIB |
| 10009165 | 10005088 | 1.71 | 63 | Palliative (P) | 2018-05-29 | 2018-06-11 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 10519073 | TRASTUZUMAB EMTANSINE |
| 10009166 | 10005090 | 1.54 | 74 | Palliative (P) | 1983-12-11 | 2018-05-11 | Carboplatin + Liposomal Doxorubicin | N | N | 10519110 | CISPLATIN + VINORELBINE |
| 10009167 | 10005093 | 1.69 | 58 | Disease modification (D) | 2019-08-13 | 2019-11-19 | ECX | null | Y | 10519170 | ERLOTINIB |
| 10009168 | 10005107 | 1.67 | 82.7 | Disease modification (D) | 2017-12-01 | 2018-04-20 | Melphalan IV High dose | 02 | N | 10520306 | TEMOZOLOMIDE + RT |
| 10009169 | 10005117 | 1.74 | 111 | Palliative (P) | 2017-10-24 | 2017-10-24 | Bortezomib +/- Dexamethasone | N | N | 10522682 | HYDROXYCARBAMIDE |
| 10009170 | 10005135 | 1.54 | null | null | 2018-08-19 | 2018-08-19 | CETUXIMAB | 2 | N | 10526752 | TOPOTECAN |
| 10009171 | 10008618 | 1.76 | 74 | Palliative (P) | 2018-11-09 | 2018-11-10 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 10527906 | CAPECITABINE + GEMCITABINE |
| 10009172 | 10005159 | null | null | Palliative (P) | 2019-08-25 | 2019-10-11 | Sorafenib | 2 | null | 10531615 | LOMUSTINE |
| 10009173 | 10005177 | 1.61 | null | Adjuvant (A) | 2019-03-03 | 2019-03-21 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 10534514 | ERLOTINIB |
| 10009174 | 10005199 | 1.72 | 63.9 | Palliative (P) | null | 2019-07-25 | Bortezomib +/- Dexamethasone | 02 | N | 10536766 | POMALIDOMIDE |
| 10009175 | 10005201 | null | 79.2 | Adjuvant (A) | 2016-06-14 | 2016-06-22 | NIVOLUMAB | 02 | N | 10536813 | BORTEZOMIB + THALIDOMIDE |
| 10009176 | 10005217 | null | 68.2 | Adjuvant (A) | 2017-04-12 | 2017-11-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | Y | 10538869 | BEAM + ALEMTUZUMAB |
| 10009177 | 10005233 | null | null | Palliative (P) | 2019-08-07 | 2019-08-07 | IMATINIB | N | N | 10541130 | CAPECITABINE + IRINOTECAN |
| 10009178 | 10005257 | null | 77.8 | Palliative (P) | 2018-03-11 | 2018-05-02 | Erlotinib | N | null | 10544006 | CAPECITABINE + CARBOPLATIN |
| 10009179 | 10005260 | 1.7 | 63.8 | Palliative (P) | 2015-03-14 | 2015-04-18 | Cytarabine HD + Rituximab | N | N | 10544316 | ENZALUTAMIDE |
| 10009180 | 10005268 | 1.71 | null | Palliative (P) | null | 2017-02-16 | Arsenic Triox + Tretinoin Ind W5-8 | N | N | 10544598 | CISPLATIN + RT |
| 10009181 | 10005302 | 1.87 | 105 | Curative (C) | 2015-04-09 | 2015-09-22 | CISPLATIN + RT | 02 | N | 10546808 | IBRUTINIB + RITUXIMAB |
| 10009182 | 10007650 | 1.73 | 79.5 | Palliative (P) | 2019-06-25 | 2019-07-08 | Cetuximab 7 day (Cycle 1) | 2 | N | 10550149 | IRINOTECAN |
| 10009183 | 10005344 | null | 98.4 | Palliative (P) | 2017-08-19 | 2017-08-28 | Methotrexate intrathecal | 02 | Y | 10551778 | IRINOTECAN |
| 10009184 | 10007656 | 0 | 82.3 | Palliative (P) | null | 2019-01-16 | EOX | N | N | 10552352 | CAPECITABINE + IRINOTECAN |
| 10009185 | 10005357 | 1.7 | null | Palliative (P) | 2019-11-01 | 2019-11-29 | Panitumumab | N | N | 10555122 | DA |
| 10009186 | 10005367 | 1.61 | 75.8 | Palliative (P) | 2018-02-28 | 2018-05-23 | Erlotinib | N | N | 10557484 | LIPOSOMAL DOXORUBICIN |
| 10009187 | 10005368 | null | 66 | Disease modification (D) | 2018-02-02 | 2018-04-11 | Vinorelbine IV | N | N | 10557618 | CETUXIMAB + OXALIPLATIN + MDG |
| 10009188 | 10007670 | 1.66 | 75.4 | Curative (C) | 2016-08-06 | 2016-09-06 | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + MITOXANTRONE + RITUXIMAB + VINCRISTINE | 02 | N | 10558140 | ECX |
| 10009189 | 10005376 | 1.83 | 63.6 | Palliative (P) | 2018-07-02 | 2018-07-02 | Chlorambucil | 2 | N | 10558553 | AFATINIB |
| 10009190 | 10005399 | 1.83 | 79.3 | Palliative (P) | 2019-03-31 | 2019-04-06 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 10562814 | IMATINIB |
| 10009191 | 10005419 | 2 | 89.1 | Palliative (P) | null | 2015-04-29 | Bendamustine + Obinutuzumab | N | N | 10223520 | CYCLOPHOSPHAMIDE |
| 10009192 | 10005443 | 1.79 | null | null | 2019-01-26 | 2019-03-04 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 10269868 | CABAZITAXEL |
| 10009193 | 10005447 | 1.59 | 108 | Palliative (P) | 2019-10-10 | 2019-11-11 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 10271252 | OXALIPLATIN + MDG + PANITUMUMAB |
| 10009194 | 10005470 | null | 74.6 | Adjuvant (A) | null | 2019-04-15 | FLUOROURACIL + MITOMYCIN + RT | N | N | 10349347 | CISPLATIN + VINORELBINE + RT |
| 10009195 | 10005502 | 1.76 | 71.1 | Curative (C) | 2019-04-03 | 2019-09-10 | Mitomycin Intravesical | 02 | N | 10420706 | ENZALUTAMIDE |
| 10009196 | 10005518 | 1.65 | 80.6 | Not known (9) | 2017-07-22 | 2017-07-26 | FLUOROURACIL + MITOMYCIN + RT | N | N | 10425847 | LOMUSTINE |
| 10009197 | 10005523 | null | 96.8 | Palliative (P) | 2018-06-01 | 2018-06-07 | Everolimus 10mg | N | N | 10430552 | PMITCEBO-R |
| 10009198 | 10005526 | 0 | 68.1 | Palliative (P) | 2018-09-22 | 2018-10-06 | ECF | N | Y | 10435336 | TAC |
| 10009199 | 10005537 | 1.77 | 86.4 | Curative (C) | 2020-01-05 | 2020-02-16 | Bortezomib + Panobinostat | 02 | N | 10445767 | PAZOPANIB |
| 10009200 | 10005557 | 1.79 | 62.5 | Disease modification (D) | 2018-03-18 | 2019-07-30 | Melphalan IV High dose | 2 | N | 10476489 | CHLORAMBUCIL + RITUXIMAB |
| 10009201 | 10005576 | 1.75 | 100 | Palliative (P) | 2019-07-13 | 2019-10-24 | OLYMPIA Trial | 02 | N | 10505211 | ABVD |
| 10009202 | 10007764 | 1.66 | 68.8 | Palliative (P) | 2019-07-14 | 2019-07-15 | PCV | N | N | 10510766 | ERLOTINIB |
| 10009203 | 10005625 | 1.61 | null | Palliative (P) | 2020-04-10 | 2020-04-15 | CARBOPLATIN + PACLITAXEL + RT | N | N | 10233873 | FCR |
| 10009204 | 10005635 | 1.75 | 81.9 | Palliative (P) | 2019-05-04 | 2019-05-10 | EOX | 02 | Y | 10350333 | CISPLATIN + FLUOROURACIL |
| 10009205 | 10006948 | 1.78 | 91.8 | Palliative (P) | null | 2016-09-30 | Docetaxel | N | N | 10250247 | DOCETAXEL |
| 10009206 | 10003611 | null | 62.2 | Palliative (P) | 2018-11-30 | 2018-12-04 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 10254888 | RITUXIMAB |
| 10009207 | 10003658 | 1.71 | 62 | Palliative (P) | null | 2019-09-24 | Rituximab | N | null | 10279108 | RITUXIMAB |
| 10009208 | 10003694 | 1.54 | 86.8 | Palliative (P) | 2015-04-05 | 2015-04-05 | Docetaxel 75mg/m2 (21 day) | N | N | 10283619 | DOCETAXEL |
| 10009209 | 10003706 | 1.6 | 88.8 | Palliative (P) | 2017-06-26 | 2017-07-10 | Docetaxel | 2 | N | 10285489 | DOCETAXEL |
| 10009210 | 10003835 | 1.62 | 61.2 | Palliative (P) | 2019-04-18 | 2019-04-18 | TRASTUZUMAB | 2 | N | 10307851 | TRASTUZUMAB |
| 10009211 | 10003845 | 1.65 | 75.6 | Palliative (P) | 2018-02-13 | 2018-02-14 | Rituximab | 02 | N | 10308579 | RITUXIMAB |
| 10009212 | 10003948 | 1.83 | 95 | Palliative (P) | 2018-09-20 | 2018-09-21 | Irinotecan + De Gramont | N | N | 10358511 | IRINOTECAN + MDG |